Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
about
The rationale for consuming cognitive enhancement drugs in university students and teachersImpact of contextual factors and substance characteristics on perspectives toward cognitive enhancementCognitive enhancers for the treatment of ADHDA compensatory role for declarative memory in neurodevelopmental disordersBrain Anatomy in Latino Farmworkers Exposed to Pesticides and NicotineDonepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkersSmart drugs "as common as coffee": media hype about neuroenhancementThe effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs.Use of illicit and prescription drugs for cognitive or mood enhancement among surgeonsOptimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteersGalantamine improves sustained attention in chronic cocaine users.Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.Sensitivity of Quantitative Signal Detection in Regards to Pharmacological NeuroenhancementMemantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.The is and ought of the Ethics of Neuroenhancement: Mind the Gap.Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.Emerging Therapeutic Enhancement Enabling Health Technologies and Their Discourses: What Is Discussed within the Health Domain?Should physicians prescribe cognitive enhancers to healthy individuals?Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.Enhancing Effects of NMDA-Receptor Blockade on Extinction Learning and Related Brain Activation Are Modulated by BMI.Cognitive enhancement by drugs in health and diseaseCurrent perspectives on pharmacotherapy of Alzheimer's disease.Touching on translation.The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement.Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.What makes deeply encoded items memorable? Insights into the levels of processing framework from neuroimaging and neuromodulation.Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.The impact of diet-based glycaemic response and glucose regulation on cognition: evidence across the lifespan.Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.Cognitive enhancement.Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety.
P2860
Q21089765-70BCAF73-2B72-4611-82AC-D75760CBE62AQ21558807-1AAEFF16-777E-44F5-866B-C3CC7EABD98DQ22251235-2BAADB57-D3B1-4785-87FE-CE616D6B3A1DQ28085679-E061F002-9F10-403B-AD0F-110904BAA7E5Q28394205-A4F8259F-67FC-4487-A032-BF09332363FEQ28476847-3DB40CE3-F50E-461D-B367-204060F138A9Q28742076-A27F5F1C-53FB-484C-B1F2-26B0A3E84E29Q30463325-4DC85AB1-5DF5-47BC-8155-5E6A02E9590BQ33777577-C4DB6EEE-68F4-402A-9E4A-4A465DFADADBQ34183988-694DFF01-4E00-4834-BDE4-58EB6438B75CQ34330838-B3606215-779F-4B86-9FAC-110B80117663Q34660460-501E303E-C668-4653-8CBC-CF287B53ACFAQ34870758-0D5042BF-EB71-4091-A1F1-C6606A3719EDQ34923586-EC5589FD-24EE-4A42-96CE-9DD04F4B3D1FQ35609711-F5978FE9-A953-45D6-BAF3-EA48D66E5DEEQ35953418-8954CA76-039C-4787-88A3-37BE68DCAD66Q35973078-8CFBD384-2D9A-4B2C-90B0-3EBE7A2F928EQ36179654-A3356ADE-5662-4313-B25E-15AD86F99EF3Q36244289-E1A2EC41-1828-4019-A907-922EEBE58AFFQ36302190-351BF0AA-4CF0-4E51-AAA3-26E872C87328Q36441885-F87B3504-D7A3-4F02-AD28-F33515F8D0A7Q36594188-05061EE9-8087-4245-86A9-BF9FF2916677Q36810065-E5ADC127-469A-43ED-869B-D07E04E9735BQ37069246-ECCA599C-7F25-4C5A-90EA-A4AAE5C9D340Q37141975-B8586E58-5F2B-4413-8CE8-B8E40C430E5BQ37267760-7C75F9AC-8DFD-42D7-967D-600322990963Q37683193-1441119B-FF1E-47DC-8967-5F11E41F1CD1Q37819134-1AAAB995-944E-4BD8-B9D9-C6DFD31D4FF0Q37827489-1C0B3C3C-8E34-4FFB-A596-2827C1311DE9Q38129279-09356073-2DC9-4BE9-A2B4-1A7CFFD1F7A9Q38176831-781AD618-2406-43A3-A3EA-4FC9E9334D0DQ38208461-7488BDDE-29CD-44E6-A31C-35E34CAF526FQ38218098-B50EE89A-551D-4F03-B372-D81A4CB8DBF2Q38248567-AEEE3D32-9002-4DED-8417-FD6384B11397Q38666482-5C2D8FA9-9721-465E-94F8-2AD72FF4839EQ38686098-67D72362-882C-4173-AD85-32B4E2F5C797Q39252587-D5885CE2-4E08-4389-8B66-A75ED2DFE610Q40610536-A579ACF1-B927-417C-825B-A868D2B78EAAQ40810950-56F64117-CE64-4465-8C50-FF3AB88E17FDQ41061816-26DA0C98-71FE-477A-B3F4-F619C64EDA43
P2860
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@ast
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@en
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@nl
type
label
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@ast
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@en
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@nl
prefLabel
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@ast
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@en
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@nl
P2093
P1476
Acetylcholinesterase inhibitor ...... ividuals: a systematic review.
@en
P2093
Dimitris Repantis
Isabella Heuser
Oona Laisney
P304
P356
10.1016/J.PHRS.2010.02.009
P577
2010-03-01T00:00:00Z